Danforth Center

In Genome Biology this week: epigenetic patterns linked to gestational age, Dichanthelium oligosanthes sequence, and more.

Researchers sequenced the desiccation-tolerant grass, Oropetium thomaeum, and analyzed its repetitive sequences.

NEW YORK (GenomeWeb) – Kultevat today said it has exclusively licensed technology to control plant gene expression from the Donald Danforth Plant Science Center.

NEW YORK (GenomeWeb) – The Donald Danforth Plant Science Center announced on Tuesday that it is part of a collaborative research project that was awarded a five-year, $20 million grant from the National Science Foundation to study the impact of climate variability, an effort that will include gen

NEW YORK (GenomeWeb News) – A research group led by the Donald Danforth Plant Science Center in St. Louis will use a $12.1 million grant from the US Department of Energy to conduct genomics-driven research to develop and improve a grass that could be an important bioenergy crop.

Dow AgroSciences has granted the Danforth Center the rights to use a promoter that allows disease-resistance genes to be introduced and to function in the cassava plant.

The funding from the Danforth Foundation will support the first phase of a three-part expansion at the Donald Danforth Plant Science Center.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Around the Regions

Premium

California Institute for Regenerative Medicine, Vermont Pharma Marketing Disclosure Bills, New England Biotech Association, US Energy Frontier Research Centers, Donald Danforth Plant Science Center, New York Biotechnology Association, Pharmaceutical Research and Manufacturers of America, Idea Networks of Biomedical Research Excellence, Pittsburgh Entrepreneur Fund, Massachusetts Life Sciences Center Accelerator Program, Maryland Technology Development Corporation, San Diego Center for Algae Biotechnology

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.